Fundraising Fox

Emerge Diagnostics

Carlsbad, US · Founded 2012 · Delaware corporation

Healthtech

Founders & leadership

RT
Robert ThompsonExecutive
JW
Jerry WilkinsExecutive
MR
Mary Rose ReastonNamed on SEC filing
PR
Phil ReastonNamed on SEC filing

Board

MC
Michael ConnorBoard director
MS
Mark SampsonBoard director
ML
Murray LappeBoard director
DM
David MillerBoard director
WQ
William QuirkBoard director
SW
Scott WolessonBoard director

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 9 rounds · 2014–2023

▶$105KraisedNov 2023 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark SampsonDirector
  • Thomas WebsterDirector
  • Murray LappeDirector
  • Greer WoodruffDirector
  • Robert ThompsonDirector
  • David SaundersExecutive Officer
  • Michael ConnorDirector
Amount sold
$105K
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedNov 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ConnorDirector
  • Murray LappeDirector
  • David RikerExecutive Officer, Director
  • Greer WoodruffDirector
  • Robert ThompsonDirector
  • Thomas WebsterDirector
  • Mark SampsonDirector
Offering amount
$500K
Amount sold
$150K
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200.4KraisedMar 2021 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas WebsterDirector
  • Mark SampsonDirector
  • Greer WoodruffDirector
  • Michael ConnorDirector
  • Robert ThompsonDirector
  • Murray LappeDirector
  • Phil ReastonExecutive Officer
  • MaryRose Cusimano-Reaston, Ph.D.Executive Officer
Offering amount
$500K
Amount sold
$200.4K
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$550KraisedOct 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ThompsonDirector
  • MaryRose Cusimano-Reaston, Ph.D.Executive Officer
  • Phil ReastonExecutive Officer
  • Murray LappeDirector
  • Mark SampsonDirector
  • Michael ConnorDirector
  • Greer WoodruffDirector
  • Thomas WebsterDirector
Offering amount
$550K
Amount sold
$550K
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$267KraisedDec 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ConnorDirector
  • Mark SampsonDirector
  • Murray LappeDirector
  • Greer WoodruffDirector
  • Thomas WebsterDirector
  • MaryRose Cusimano-ReastonExecutive Officer
  • Phil ReastonExecutive Officer
  • Robert ThompsonDirector
Offering amount
$500K
Amount sold
$267K
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJun 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ThompsonExecutive Officer, Director
  • Murray LappeDirector
  • William QuirkDirector
  • David MillerDirector
  • Mary Rose ReastonExecutive Officer
  • Phil ReastonExecutive Officer
  • Jerry WilkinsExecutive Officer, Director
  • Michael ConnorDirector
  • Mark SampsonDirector
  • Scott WolessonDirector
Offering amount
$8M
Amount sold
$250K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedJun 2016 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ThompsonExecutive Officer, Director
  • Mary Rose ReastonExecutive Officer
  • Michael ConnorDirector
  • Mark SampsonDirector
  • Murray LappeDirector
  • Jerry WilkinsExecutive Officer, Director
  • David MillerDirector
  • William QuirkDirector
  • Phil ReastonExecutive Officer
  • Scott WolessonDirector
Offering amount
$2.4M
Amount sold
$1.9M
Proceeds to insiders
$101.3K
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedDec 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil ReastonExecutive Officer
  • Jerry WilkinsExecutive Officer
  • Robert ThompsonExecutive Officer
  • Mary Rose ReastonExecutive Officer
Offering amount
$3M
Amount sold
$2.8M
First sale
Nov 2014
Incorporated
Limited Liability Company, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Emerge Diagnostics raises fresh capital to detect injuries in workers compensation industry - MedCity Newsmedcitynews.com · Jun 2016Emerge Diagnostics Raises $3M in Financing - FinSMEsfinsmes.com · Feb 2015

Frequently asked questions

How much funding has Emerge Diagnostics raised?
Emerge Diagnostics has disclosed $7M raised across 9 rounds.
Where is Emerge Diagnostics headquartered?
Emerge Diagnostics is headquartered in Carlsbad, US.